Advisory Committees
ADAP Advocacy leverages patient advocates and other public health stakeholders to serve on numerous patient advisory committees:
State ADAP Drug Formulary Patient Advisory Committee
RE: Drug Formularies
ADAP Advocacy works to improve access to timely, appropriate care and treatment for people living with HIV/AIDS being served by the State AIDS Drug Assistance Programs (ADAPs) under the Ryan White HIV/AIDS Program, including promoting robust drug formularies to best serve the needs of clients. Whenever feasible, ADAP Advocacy strongly supports "open" drug formularies.
Long-Acting Injectables Patient Advisory Committee
RE: Long-Acting Injectables
ADAP Advocacy strives to identify best practices on how to improve patient access to long-acting injectable (LAIs) therapies for the treatment of (and prevention of) HIV/AIDS. As general guidelines, they would be designed to help State AIDS Drug Assistance Programs (ADAPs), and other relevant payers, remove the barriers to accessing injectable HIV-related therapies, as well as other non-antiretroviral (ARV), health-related injectable therapies.
340B Patient Advisory Committee
RE: 340B Drug Pricing Program
ADAP Advocacy ensures the voice of people living with HIV/AIDS shall always be at the table and the center of the discussion, including on how supports and services are financed under the Ryan White HIV/AIDS Program. To that end, reforming the 340B Drug Pricing Program is of paramount concern by returning the program to its original legislative intent: putting the patient first.